-
Mashup Score: 0Reflecting on a Decade of Sofosbuvir Use for Hepatitis C Virus Treatment – Gastroenterology & Hepatology - 2 month(s) ago
Ira M. Jacobson, MD Professor of Medicine Director of Hepatology Research NYU Langone Health New York, New York G & H Sofosbuvir was approved with ribavirin or pegylated interferon plus ribavirin just over 10 years ago for the treatment of hepatitis C virus infection. Thinking back over the past decade of its use, why was sofosbuvir studied in this area in the first place? IJ Sofosbuvir is a nucleotide analog inhibitor of hepatitis C virus (HCV) NS5B polymerase. The drug mimics one of the normal building
Categories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 8Hepatitis C Virus | Annals of Internal Medicine - 4 year(s) ago
Hepatitis C virus (HCV) is the most common bloodborne pathogen in the United States, chronically affecting approximately 2.4 million Americans, most of whom are unaware of the infection. Highly eff…
Source: www.acpjournals.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
“Reflecting on a Decade of Sofosbuvir Use for Hepatitis C Virus Treatment” with Ira M. Jacobson, MD https://t.co/fRDjEpuD1F @nyulangone #hepatitsc